Search research articles
Contact Us
Filters
Showing results (51-60 of 76) with videos related to
Page
of 8
Sort By:
International Journal of Hematology
|
May 20, 2011
Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia: a retrospective safety analysis
Yukio Kobayashi, Hisashi Sakamaki, Shin Fujisawa, et al.
Leukemia Research
|
September 29, 2006
Clinical features and outcome of T-lineage acute lymphoblastic leukemia in adults: a low initial white blood cell count, as well as a high count predict decreased survival rates
Masamitsu Yanada, Itsuro Jinnai, Jin Takeuchi, et al.
European Journal of Haematology
|
January 24, 2007
Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome
Masamitsu Yanada, Tadashi Matsushita, Norio Asou, et al.
International Journal of Hematology
|
January 8, 2011
Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
Minoru Yoshida, Nobu Akiyama, Hiroyuki Fujita, et al.
International Journal of Hematology
|
May 29, 2012
Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia: the JALSG GML200 Study
Atsushi Wakita, Shigeki Ohtake, Satoru Takada, et al.
Haematologica
|
January 29, 2008
Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy
Masamitsu Yanada, Jin Takeuchi, Isamu Sugiura, et al.
Leukemia Research
|
January 18, 2011
BCR-ABL1 mutations in patients with imatinib-resistant Philadelphia chromosome-positive leukemia by use of the PCR-Invader assay
Takaaki Ono, Shuichi Miyawaki, Fumihiko Kimura, et al.
Blood
|
November 8, 2003
Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia
Kazutaka Ozeki, Hitoshi Kiyoi, Yuka Hirose, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2005
High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group
Masamitsu Yanada, Jin Takeuchi, Isamu Sugiura, et al.
International Journal of Hematology
|
February 25, 2022
A phase II randomized study evaluating azacitidine versus conventional care regimens in newly diagnosed elderly Japanese patients with unfavorable acute myeloid leukemia
Hiroatsu Iida, Kazunori Imada, Yasunori Ueda, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 76) with videos related to
Sort By:
Page
of 8
International Journal of Hematology
|
May 20, 2011
Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia: a retrospective safety analysis
Yukio Kobayashi, Hisashi Sakamaki, Shin Fujisawa, et al.
Leukemia Research
|
September 29, 2006
Clinical features and outcome of T-lineage acute lymphoblastic leukemia in adults: a low initial white blood cell count, as well as a high count predict decreased survival rates
Masamitsu Yanada, Itsuro Jinnai, Jin Takeuchi, et al.
European Journal of Haematology
|
January 24, 2007
Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome
Masamitsu Yanada, Tadashi Matsushita, Norio Asou, et al.
International Journal of Hematology
|
January 8, 2011
Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
Minoru Yoshida, Nobu Akiyama, Hiroyuki Fujita, et al.
International Journal of Hematology
|
May 29, 2012
Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia: the JALSG GML200 Study
Atsushi Wakita, Shigeki Ohtake, Satoru Takada, et al.
Haematologica
|
January 29, 2008
Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy
Masamitsu Yanada, Jin Takeuchi, Isamu Sugiura, et al.
Leukemia Research
|
January 18, 2011
BCR-ABL1 mutations in patients with imatinib-resistant Philadelphia chromosome-positive leukemia by use of the PCR-Invader assay
Takaaki Ono, Shuichi Miyawaki, Fumihiko Kimura, et al.
Blood
|
November 8, 2003
Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia
Kazutaka Ozeki, Hitoshi Kiyoi, Yuka Hirose, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2005
High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group
Masamitsu Yanada, Jin Takeuchi, Isamu Sugiura, et al.
International Journal of Hematology
|
February 25, 2022
A phase II randomized study evaluating azacitidine versus conventional care regimens in newly diagnosed elderly Japanese patients with unfavorable acute myeloid leukemia
Hiroatsu Iida, Kazunori Imada, Yasunori Ueda, et al.
Page
of 8